Yazar "Dane, Faysal" için listeleme

Toplam kayıt 3, listelenen: 1-3

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine plus nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

Yalcin, Suayib; Dane, Faysal; Oksuzoglu, Berna; Ozdemir, Nuriye Yildirim; Isikdogan, Abdurrahman; Ozkan, Metin; Kilickap, Saadettin (Bmc, 2020)

BackgroundCombination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL) associated with this combination therapy when administered ...
Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).

Gumus, Mahmut; Dane, Faysal; Karabulut, Bulent; Uygun, Kazim; Aydin, Kubra; Orhan, Bulent; Ozen, Ridvan Seckin (Amer Soc Clinical Oncology, 2015)

…
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study

Dane, Faysal; Ozgurdal, Kirhan; Yalcin, Suayib; Benekli, Mustafa; Aykan, Nuri Faruk; Yucel, Idris; Yumuk, Perran Fulden (Bmj Publishing Group, 2020)

Objectives Regorafenib improved overall survival in patients with metastatic colorectal cancer (mCRC) refractory to standard therapies in two randomised, phase III trials, but has not been evaluated in Turkey. REGARD ...